Alzheimer's Disease
What's New
Last Posted: May 16, 2024
- The Role of X Chromosome in Alzheimer's Disease Genetics.
Michael E Belloy et al. medRxiv 2024 - Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer's Disease between the Chinese and European Populations.
F Li et al. J Prev Alzheimers Dis 2024 11(3) 701-709 - APOE4 homozygozity represents a distinct genetic form of Alzheimer’s disease
- Explainable machine learning for predicting conversion to neurological disease: Results from 52,939 medical records.
Christina Felix et al. Digit Health 2024 1020552076241249286 - Interpreting artificial intelligence models: a systematic review on the application of LIME and SHAP in Alzheimer's disease detection.
Viswan Vimbi et al. Brain Inform 2024 11(1) 10 - Performance Evaluation of Deep, Shallow and Ensemble Machine Learning Methods for the Automated Classification of Alzheimer's Disease.
Noushath Shaffi et al. Int J Neural Syst 2024 2450029 - Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals.
Elaheh Moradi et al. Alzheimers Res Ther 2024 16(1) 46 - Ranking and filtering of neuropathology features in the machine learning evaluation of dementia studies.
Mohammed D Rajab et al. Brain Pathol 2024 e13247 - Early dementia diagnosis: blood proteins reveal at-risk people The results of a large-scale screening study could be used to develop blood tests to diagnose diseases such as Alzheimer’s before symptoms take hold.
M Naddaf, Nature, February 13, 2024 - Genetic risk for attention-deficit/hyperactivity disorder predicts cognitive decline and development of Alzheimer's disease pathophysiology in cognitively unimpaired older adults.
Douglas T Leffa et al. Mol Psychiatry 2022 28(3) 1248-1255 - Applications of Artificial Intelligence in the Neuropsychological Assessment of Dementia: A Systematic Review.
Isabella Veneziani et al. J Pers Med 2024 14(1) - Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis.
Jianguo Zhou et al. J Alzheimers Dis 2024 - Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening
G Nicolas et al, Genetics in Med, January 24, 2024 - Advertisement by medical facilities as an opportunity route of APOE genetic testing in Japan: a website analysis.
Kenichiro Sato et al. J Community Genet 2024 - Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.
Lisa Waterink et al. Alzheimers Res Ther 2024 16(1) 1 - A Case-Control Clinical Trial on a Deep Learning-Based Classification System for Diagnosis of Amyloid-Positive Alzheimer's Disease.
Jong Bin Bae et al. Psychiatry Investig 2024 20(12) 1195-1203 - Effect of Comorbidities Features in Machine Learning Models for Survival Analysis to Predict Prodromal Alzheimer's Disease.
Ferial Abuhantash et al. Annu Int Conf IEEE Eng Med Biol Soc 2023 20231-4 - Direct to Consumer Biomarker Testing for Alzheimer Disease—Are We Ready for the Insurance Consequences?
JJ Arias et al, JAMA Neurology, December 18, 2023 - Attitudes toward pre-symptomatic screening for Alzheimer’s dementia in five European countries: a comparison of family members of people with Alzheimer’s dementia versus non-family members
IA Angelidou et al, Frontiers Genetics, December 2023 - How CRISPR gene editing could help treat Alzheimer’s
T Thompson, Nature, December 11, 2023 - Organ aging signatures in the plasma proteome track health and disease.
Hamilton Se-Hwee Oh et al. Nature 2023 12 (7990) 164-172 - Early Stage Detection of Alzheimer's Disease With Microsoft Azure Based Deep Learning.
Krish Mittal et al. Res Sq 2023 - APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.
Michael E Belloy et al. JAMA Neurol 2023 11 - Real-world prediction of preclinical Alzheimer's disease with a deep generative model.
Uiwon Hwang et al. Artif Intell Med 2023 144102654 - Pathway-specific polygenic scores for Alzheimer's disease are associated with changes in brain structure in younger and older adults.
Judith R Harrison et al. Brain Commun 2023 5(5) fcad229 - Deep Learning of Speech Data for Early Detection of Alzheimer's Disease in the Elderly.
Kichan Ahn et al. Bioengineering (Basel) 2023 10(9) - Paving the Way for Predicting the Progression of Cognitive Decline: The Potential Role of Machine Learning Algorithms in the Clinical Management of Neurodegenerative Disorders.
Caterina Formica et al. J Pers Med 2023 13(9) - Consumers Can Now Buy a Blood Test to Evaluate Their Alzheimer Disease Risk, but Should They?
R Rubin, JAMA, September 13, 2023 - Association of regular use of ibuprofen and paracetamol, genetic susceptibility, and new-onset dementia in the older population.
Yuanyuan Zhang et al. Gen Hosp Psychiatry 2023 84226-233 - Emerging diagnostics and therapeutics for Alzheimer disease.
Wade K Self et al. Nat Med 2023 9 - Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia.
Laura M Winchester et al. Alzheimers Dement 2023 - Radiomics and Artificial Intelligence for the Diagnosis and Monitoring of Alzheimer's Disease: A Systematic Review of Studies in the Field.
Roberta Bevilacqua et al. J Clin Med 2023 12(16) - Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review.
Robin J Borchert et al. Alzheimers Dement 2023 - Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease.
Erik C B Johnson et al. Nat Med 2023 8 - Association of APOE ε4 Status With Long-term Declines in Odor Sensitivity, Odor Identification, and Cognition in Older US Adults.
Matthew S GoodSmith et al. Neurology 2023 - Development and validation of a deep-broad ensemble model for early detection of Alzheimer's disease.
Peixian Ma et al. Front Neurosci 2023 171137557 - XGBoost-SHAP-based interpretable diagnostic framework for alzheimer's disease.
Fuliang Yi et al. BMC Med Inform Decis Mak 2023 23(1) 137 - Radiomics for Alzheimer's Disease: Fundamental Principles and Clinical Applications.
Eleni Georgiadou et al. Adv Exp Med Biol 2023 1424297-311 - Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life.
Keenan A Walker et al. Sci Transl Med 2023 7 (705) eadf5681 - Identifying healthy individuals with Alzheimer’s disease neuroimaging phenotypes in the UK Biobank
T Azevedo et al, Comm Med, July 20, 2023 - Using artificial intelligence to learn optimal regimen plan for Alzheimer's disease.
Kritib Bhattarai et al. J Am Med Inform Assoc 2023 - HomeADScreen: Developing Alzheimer's disease and related dementia risk identification model in home healthcare.
Maryam Zolnoori et al. Int J Med Inform 2023 177105146 - AD-BERT: Using Pre-trained Language Model to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
Chengsheng Mao et al. J Biomed Inform 2023 104442 - Characterizing subgroup performance of probabilistic phenotype algorithms within older adults: a case study for dementia, mild cognitive impairment, and Alzheimer's and Parkinson's diseases.
Juan M Banda et al. JAMIA Open 2023 6(2) ooad043 - Development and validation of an interpretable machine learning model-Predicting mild cognitive impairment in a high-risk stroke population.
Feng-Juan Yan et al. Front Aging Neurosci 2023 151180351 - Mendelian randomization evidence for the causal effects of socio-economic inequality on human longevity among Europeans.
Chao-Jie Ye et al. Nat Hum Behav 2023 - Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer's Disease: An Overview of Tests for Clinical Practice in the United States and Europe.
L Iaccarino et al. J Prev Alzheimers Dis 2023 10(3) 426-442 - Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program.
T Walsh et al. J Prev Alzheimers Dis 2023 10(3) 453-463 - Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.
Michael Wainberg et al. Alzheimers Res Ther 2023 15(1) 113 - Passive digital markers for Alzheimer's disease and other related dementias: A systematic evidence review.
Britain Taylor et al. J Am Geriatr Soc 2023 - Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia.
Ida Juul Rasmussen et al. Eur Heart J 2023 - Apolipoprotein E (APOE) Haplotypes in Healthy Subjects from Worldwide Macroareas: A Population Genetics Perspective for Cardiovascular Disease, Neurodegeneration, and Dementia.
Paolo Abondio et al. Curr Issues Mol Biol 2023 45(4) 2817-2831 - How one man's rare Alzheimer’s mutation delayed the onset of disease Genetic resilience found in a person predisposed to early-onset dementia could potentially lead to new treatments.
S Reardon, Nature, May 16, 2023 - Machine learning for the prediction of cognitive impairment in older adults.
Wanyue Li et al. Front Neurosci 2023 171158141 - The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer's disease: a natural language processing study.
Willem S Eikelboom et al. Alzheimers Res Ther 2023 15(1) 94 - 'It Totally Backfired': The Pitfalls of Alzheimer's Genetic Testing
J Steenhuysen, Medscape, April 24, 2023 - Demographic diversity of genetic databases used in Alzheimer's disease research.
Robert I Field et al. Hum Genet - Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
Lawrence S Honig et al. JAMA Netw Open (4) e238214 - Use of artificial intelligence techniques for detection of mild cognitive impairment: A systematic scoping review.
Li JuanVivian Quek et al. J Clin Nurs 2023 - Deep learning-based polygenic risk analysis for Alzheimer's disease prediction.
Xiaopu Zhou et al. Communications medicine 2023 4 (1) 49 - Interaction analysis of ancestry-enriched variants with APOE-ɛ4 on MCI in the Study of Latinos-Investigation of Neurocognitive Aging.
Einat Granot-Hershkovitz et al. Scientific reports 2023 13(1) 5114 - Conquering Alzheimer's: a look at the therapies of the future Researchers are looking to drug combinations, vaccines and gene therapy as they forge the next generation of treatments for the condition.
A Abbot, Nature, April 4, 2023 - Functional activity level reported by an informant is an early predictor of Alzheimer's disease.
Alexandra Vik et al. BMC geriatrics 2023 23(1) 205 - Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease.
Min Qiao et al. Annals of clinical and translational neurology 2023 - The Effects of Subjective Cognitive Decline on APOE Genotype Disclosure in the Butler Hospital Alzheimer's Prevention Registry.
A K W Lee et al. The journal of prevention of Alzheimer's disease 2023 10(2) 152-161 - Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.
Sayeh Bayat et al. Journal of Alzheimer's disease : JAD 2023 - Predicting Conversion from Subjective Cognitive Decline to Mild Cognitive Impairment and Alzheimer's Disease Dementia Using Ensemble Machine Learning.
Marta M Dolcet-Negre et al. Journal of Alzheimer's disease : JAD 2023 - Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score.
Q Gao et al. JAR life 2023 111-8 - Genetic propensity for cerebral amyloidosis and risk of mild cognitive impairment and Alzheimer's disease within a cognitive reserve framework.
Niki Mourtzi et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2023 - Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer's disease.
Angelika Caputo et al. Alzheimer's research & therapy 2023 15(1) 45 - Automated Video Analysis of Audio-Visual Approaches to Predict and Detect Mild Cognitive Impairment and Dementia in Older Adults.
Che-Sheng Chu et al. Journal of Alzheimer's disease : JAD 2023 - Alzheimer's Disease: An Updated Overview of Its Genetics.
Jesús Andrade-Guerrero et al. International journal of molecular sciences 2023 24(4) - Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders.
Celtia Domínguez-Fernández et al. International journal of molecular sciences 2023 24(4) - Association of African Ancestry-Specific APOE Missense Variant R145C With Risk of Alzheimer Disease.
Yann Le Guen et al. JAMA 2023 2 (7) 551-560 - Type 2 Diabetes Mellitus and its comorbidity, Alzheimer's disease: Identifying critical microRNA using machine learning.
Hind Alamro et al. Frontiers in endocrinology 2023 131084656 - Drug trial for Alzheimer's disease is a game changer.
Eric M Reiman et al. Nature 2023 2 - A Deep Learning Approach to Predict Chronological Age.
Husam Lahza et al. Healthcare (Basel, Switzerland) 2023 11(3) - The Alzheimer’s risk gene APOE modulates the gut–brain axis
AM Pena et al, Nature, February 6, 2023 - A novel cascade machine learning pipeline for Alzheimer's disease identification and prediction.
Kun Zhou et al. Frontiers in aging neuroscience 2023 141073909 - Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia.
Malo Gaubert et al. Frontiers in psychiatry 2023 131010273 - Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease.
Shahram Oveisgharan et al. Neurology 2023 - Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
Zhu Yueli et al. Cells 2023 12(1) - Explainable machine learning aggregates polygenic risk scores and electronic health records for Alzheimer's disease prediction.
Gao Xiaoyi Raymond et al. Scientific reports 2023 13(1) 450 - Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort.
Saleh Rasha N M et al. Alzheimer's research & therapy 2023 15(1) 10 - CAD-ALZ: A Blockwise Fine-Tuning Strategy on Convolutional Model and Random Forest Classifier for Recognition of Multistage Alzheimer's Disease.
Abbas Qaisar et al. Diagnostics (Basel, Switzerland) 2023 13(1) - Ensemble learning using traditional machine learning and deep neural network for diagnosis of Alzheimer's disease.
Nguyen Dong et al. IBRO neuroscience reports 2023 13255-263 - Validity of three risk prediction models for dementia or cognitive impairment in Australia.
Geethadevi Gopisankar M et al. Age and ageing 2022 51(12) - [The current applicating state of neural network-based electroencephalogram diagnosis of Alzheimer's disease].
Liu Yi et al. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 2022 39(6) 1233-1239 - Alzheimer's disease and related dementias among aging veterans: Examining gene-by-environment interactions with post-traumatic stress disorder and traumatic brain injury.
Logue Mark W et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022 - Polygenic resilience score may be sensitive to preclinical Alzheimer's disease changes.
Eissman Jaclyn M et al. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2022 28449-460 - Artificial Intelligence Tools to Evaluate Language and Speech Patterns in Alzheimer's Disease.
Favaro Anna et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022 18 Suppl 2e064913 - Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
Boerwinkle Anna H et al. The Lancet. Neurology 2022 22(1) 55-65 - Diagnostic performance of magnetic resonance imaging-based machine learning in Alzheimer's disease detection: a meta-analysis.
Hu Jiayi et al. Neuroradiology 2022 - MRI-based machine learning model: A potential modality for predicting cognitive dysfunction in patients with type 2 diabetes mellitus.
Xu Zhigao et al. Frontiers in bioengineering and biotechnology 2022 101082794 - Spontaneous speech feature analysis for alzheimer's disease screening using a random forest classifier.
Hason Lior et al. Frontiers in digital health 2022 4901419 - Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring.
Ashton Nicholas J et al. Nature medicine 2022 - A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data.
Tan Wei Ying et al. Journal of Alzheimer's disease : JAD 2022 - Cost-effectiveness of a gene sequencing test for Alzheimer's disease in Ontario.
Iragorri Nicolas et al. Journal of community genetics 2022 - Automated differential diagnosis of dementia syndromes using FDG PET and machine learning.
Perovnik Matej et al. Frontiers in aging neuroscience 2022 141005731 - Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.
Holstege Henne et al. Nature genetics 2022 - Leveraging speech and artificial intelligence to screen for early Alzheimer's disease and amyloid beta positivity.
Fristed Emil et al. Brain communications 2022 4(5) fcac231 - The long road to a cure for Alzheimer's disease is paved with failures.
Moutinho Sofia et al. Nature medicine 2022 28(11) 2228-2231 - Alzheimer’s risk variant APOE4 linked to myelin-assembly malfunction
K Carlstrom et al Nature, November 16, 2022 - A Computerized Analysis with Machine Learning Techniques for the Diagnosis of Parkinson's Disease: Past Studies and Future Perspectives.
Rana Arti et al. Diagnostics (Basel, Switzerland) 2022 12(11) - Multimodal ensemble model for Alzheimer's disease conversion prediction from Early Mild Cognitive Impairment subjects.
Velazquez Matthew et al. Computers in biology and medicine 2022 151(Pt A) 106201 - Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics.
Migliore Lucia et al. Nature reviews. Neurology 2022 18(11) 643-660 - Diabetes and Alzheimer's disease: shared genetic susceptibility?
J Hardy et al, The Lancet Neurology, November 1, 2022 - Assessment of the genetic and clinical determinants of hip fracture risk: Genome-wide association and Mendelian randomization study.
Nethander Maria et al. Cell reports. Medicine 2022 3(10) 100776 - Development of an artificial intelligence-based diagnostic model for Alzheimer's disease.
Fujita Kazuki et al. Aging medicine (Milton (N.S.W)) 2022 5(3) 167-173 - Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
Katsumata Yuriko et al. Neurobiology of disease 2022 105880 - Ethics of digital therapeutics (DTx).
Refolo P et al. European review for medical and pharmacological sciences 2022 26(18) 6418-6423 - Blood Leukocyte Counts in Alzheimer Disease
J Luo et al, JAMA Network Open - A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study.
Cheung Carol Y et al. The Lancet. Digital health 2022 - Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease.
Wu Xinxing et al. Journal of Alzheimer's disease : JAD 2022 - Psychiatric and Psychosocial Characteristics of a Cohort of Spanish Individuals Attending Genetic Counseling Due to Risk for Genetically Conditioned Dementia.
Sobregrau Pau et al. Journal of Alzheimer's disease reports 2022 6(1) 461-478 - Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gap
CR Marshall et al, The Lancet Digital Health, September 30, 2022 - On the reliability of deep learning-based classification for Alzheimer's disease: Multi-cohorts, multi-vendors, multi-protocols, and head-to-head validation.
Song Yeong-Hun et al. Frontiers in neuroscience 2022 16851871 - High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.
Sturchio Andrea et al. Journal of Alzheimer's disease : JAD 2022 - Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
Clark Kaylyn et al. Journal of Alzheimer's disease : JAD 2022 89(1) 1-12 - Develop a diagnostic tool for dementia using machine learning and non-imaging features.
Wang Huan et al. Frontiers in aging neuroscience 2022 14945274 - Predicting conversion of brain β-amyloid positivity in amyloid-negative individuals.
Park Chae Jung et al. Alzheimer's research & therapy 2022 14(1) 129 - Data-driven causal model discovery and personalized prediction in Alzheimer's disease.
Zheng Haoyang et al. NPJ digital medicine 2022 5(1) 137 - The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores.
Page Madeline L et al. Communications biology 2022 5(1) 899 - Development of a deep learning network for Alzheimer's disease classification with evaluation of imaging modality and longitudinal data.
Deatsch Alison et al. Physics in medicine and biology 2022 - HTLML: Hybrid AI Based Model for Detection of Alzheimer's Disease.
Sharma Sarang et al. Diagnostics (Basel, Switzerland) 2022 12(8) - Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment.
Chun Min Young et al. Frontiers in aging neuroscience 2022 14898940 - A family looks for answers into why so many of them develop Alzheimer's disease
J Hamilton, NPR, August 25, 2022 - Diagnostic accuracy study of automated stratification of Alzheimer's disease and mild cognitive impairment via deep learning based on MRI.
Chen Xiaowen et al. Annals of translational medicine 2022 10(14) 765 - Causal machine learning for healthcare and precision medicine.
Sanchez Pedro et al. Royal Society open science 2022 9(8) 220638 - Multi-feature computational framework for combined signatures of dementia in underrepresented settings.
Moguilner Sebastian et al. Journal of neural engineering 2022 - Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America.
Takada Leonel Tadao et al. Alzheimer's research & therapy 2022 14(1) 108 - Investigating the power of eyes open resting state EEG for assisting in dementia diagnosis.
Jennings Jack L et al. Alzheimer's research & therapy 2022 14(1) 109 - Genetics of the human microglia regulome refines Alzheimer's disease risk loci.
Kosoy Roman et al. Nature genetics 2022 54(8) 1145-1154 - A Study of Dementia Prediction Models Based on Machine Learning with Survey Data of Community-Dwelling Elderly People in China.
Xu Qing et al. Journal of Alzheimer's disease : JAD 2022 - Geriatricians' Perspectives on the Multiple Dimensions of Utility of Genetic Testing for Alzheimer's Disease: A Qualitative Study.
Arias Jalayne J et al. Journal of Alzheimer's disease : JAD 2022 - Measurement of neurodegeneration using a multivariate early frame amyloid PET classifier.
Matthews Dawn C et al. Alzheimer's & dementia (New York, N. Y.) 2022 8(1) e12325 - The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer's disease and estimate 5-year risks of cognitive decline and dementia.
Alty Jane et al. BMC neurology 2022 22(1) 266 - Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.
Tam A et al. The journal of prevention of Alzheimer's disease 2022 9(3) 400-409 - Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Kirola Laxmi et al. Molecular neurobiology 2022 - Multimodal deep learning for Alzheimer’s disease dementia assessment
S Qiu et al, Nature Comms, June 20, 2022 - Genome-wide association studies for Alzheimer's disease: bigger is not always better.
Escott-Price Valentina et al. Brain communications 2022 4(3) fcac125 - Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer's disease outside of the APOE region.
de la Fuente Javier et al. PLoS genetics 2022 18(6) e1010208 - Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease
Y Le Guen et al, JAMA Neurology, May 31, 2022 - Rare APOE Missense Variants—Can We Overcome APOE ε4 and Alzheimer Disease Risk?
GD Rabinovici et al, JAMA Neurology, May 31, 2022 - Deep Learning-Based Multilevel Classification of Alzheimer's Disease Using Non-invasive Functional Near-Infrared Spectroscopy.
Ho Thi Kieu Khanh et al. Frontiers in aging neuroscience 2022 14810125 - Development of a machine learning model to predict mild cognitive impairment using natural language processing in the absence of screening.
Penfold Robert B et al. BMC medical informatics and decision making 2022 22(1) 129 - Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
Han Seung-Hyup et al. Journal of Alzheimer's disease : JAD 2022 - Predicting Amyloid Positivity in Cognitively Unimpaired Older Adults: A Machine Learning Approach Using the A4 Data.
Petersen Kellen K et al. Neurology 2022 - Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.
Alvarez-Mora Maria Isabel et al. International journal of molecular sciences 2022 23(8) - Radiomics Analysis of Brain [F]FDG PET/CT to Predict Alzheimer's Disease in Patients with Amyloid PET Positivity: A Preliminary Report on the Application of SPM Cortical Segmentation, Pyradiomics and Machine-Learning Analysis.
Alongi Pierpaolo et al. Diagnostics (Basel, Switzerland) 2022 12(4) - Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease.
Ramanan Vijay K et al. Acta neuropathologica 2022 - Combining human and machine intelligence for clinical trial eligibility querying.
Fang Yilu et al. Journal of the American Medical Informatics Association : JAMIA 2022 - Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.
Kaivola Karri et al. Brain : a journal of neurology 2022 - Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
Stevenson-Hoare Joshua et al. Brain : a journal of neurology 2022 - A high-generalizability machine learning framework for predicting the progression of Alzheimer’s disease using limited data
C Wang et al, NPJ Digital Medicine, April 12, 2022 - Exploratory Research on Key Technology of Human-Computer Interactive 2.5-Minute Fast Digital Early Warning for Mild Cognitive Impairment.
Li Nan et al. Computational intelligence and neuroscience 2022 20222495330 - Association of Genetic Variants Linked to Late-Onset Alzheimer Disease With Cognitive Test Performance by Midlife
SC Zimmerman et al, JAMA Network Open, April 4, 2022 - New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez et al, Nature Genetics, April 4, 2022 - Identification of subjective cognitive decline due to Alzheimer's disease using multimodal MRI combining with machine learning.
Lin Hua et al. Cerebral cortex (New York, N.Y. : 1991) 2022 - Predicting diagnosis 4 years prior to Alzheimer's disease incident.
Qiu Anqi et al. NeuroImage. Clinical 2022 34102993 - Application of predictive models in boosting power of Alzheimer's disease clinical trials: A post hoc analysis of phase 3 solanezumab trials.
Ezzati Ali et al. Alzheimer's & dementia (New York, N. Y.) 2022 8(1) e12223 - Cognitive Impairment of Patient With Neurological Cerebrovascular Disease Using the Artificial Intelligence Technology Guided by MRI.
Zhang Lifang et al. Frontiers in public health 2022 9813641 - Voxel-based morphometry and a deep learning model for the diagnosis of early Alzheimer's disease based on cerebral gray matter changes.
Huang Huaidong et al. Cerebral cortex (New York, N.Y. : 1991) 2022 - Ten years of image analysis and machine learning competitions in dementia.
Bron Esther E et al. NeuroImage 2022 119083 - Evaluation of Neuro Images for the Diagnosis of Alzheimer's Disease Using Deep Learning Neural Network.
A Ahila et al. Frontiers in public health 2022 10834032 - The Road to Personalized Medicine in Alzheimer's Disease: The Use of Artificial Intelligence.
Silva-Spínola Anuschka et al. Biomedicines 2022 10(2) - Discrimination of the Cognitive Function of Community Subjects Using the Arterial Pulse Spectrum and Machine-Learning Analysis.
Hsiu Hsin et al. Sensors (Basel, Switzerland) 2022 22(3) - A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?
Galasko Douglas R et al. Journal of Alzheimer's disease : JAD 2022 - Molecular map of the human blood–brain barrier reveals links to Alzheimer’s disease
Nature Research Briefings, February 14, 2022 - Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer's disease and frontotemporal dementia.
Pagnon de la Vega María et al. BMC genomics 2022 23(1) 99 - Fully automated discrimination of Alzheimer's disease using resting-state electroencephalography signals.
Ding Yue et al. Quantitative imaging in medicine and surgery 2022 12(2) 1063-1078 - Artificial intelligence applications and robotic systems in Parkinson's disease (Review).
Perju-Dumbrava Lacramioara et al. Experimental and therapeutic medicine 2022 23(2) 153 - AlzCode: a Platform for Multiview Analysis of Genes Related to Alzheimer's Disease.
Lin Cui-Xiang et al. Bioinformatics (Oxford, England) 2022 - Comparing two artificial intelligence software packages for normative brain volumetry in memory clinic imaging.
Zaki Lara A M et al. Neuroradiology 2022 - Deep learning improves utility of tau PET in the study of Alzheimer's disease.
Zou James et al. Alzheimer's & dementia (Amsterdam, Netherlands) 2022 13(1) e12264 - Major depression disorder diagnosis and analysis based on structural magnetic resonance imaging and deep learning.
Wang Yu et al. Journal of integrative neuroscience 2022 20(4) 977-984 - Artificial Intelligence empowered recruitment for clinical trials.
Linz Nicklas et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021 17 Suppl 8e050304 - CAA and related co-morbidities in Down syndrome and Alzheimer disease.
Kumar Amisha et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021 17 Suppl 2e058726 - Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer's Disease With High Performance Computing.
Zhang Fan et al. Frontiers in artificial intelligence 2021 4798962 - Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer's Disease.
Talwar Puneet et al. Frontiers in genetics 2021 12722221 - Extended Application of Digital Clock Drawing Test in the Evaluation of Alzheimer's Disease Based on Artificial intelligence and the Neural Basis.
Zheng Xiaoran et al. Current Alzheimer research 2021 - Multi-Modal Data Analysis for Alzheimer's Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features.
Ying Qi et al. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2021 20213586-3591 - Alzheimer's Disease Classification Using 2D Convolutional Neural Networks.
Liang Gongbo et al. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2021 20213008-3012 - Identifying and evaluating clinical subtypes of Alzheimer's disease in care electronic health records using unsupervised machine learning.
Alexander Nonie et al. BMC medical informatics and decision making 2021 21(1) 343 - Using Verb Fluency, Natural Language Processing, and Machine Learning to Detect Alzheimer's Disease.
Soni Aradhana et al. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2021 20212282-2285 - A needle for Alzheimer’s in a haystack of claims data
E Gunney et al, Nature Aging, December 2021 - Assessing the Views of Professionals, Patients, and Care Partners Concerning the Use of Computer Tools in Memory Clinics: International Survey Study.
van Gils Aniek M et al. JMIR formative research 2021 5(12) e31053 - Predictive value of ATN biomarker profiles in estimating disease progression in Alzheimer's disease dementia.
Ezzati Ali et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2021 17(11) 1855-1867 - Machine Learning in Neuro-Oncology, Epilepsy, Alzheimer's Disease, and Schizophrenia.
English Mason et al. Acta neurochirurgica. Supplement 2021 134349-361 - Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer's Disease Spectrum.
Nilsson Nathalie I V et al. Genes 2021 12(11) - DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer's, Related Tauopathies and Genetic Tauopathies.
Zimmer-Bensch Geraldine et al. Cells 2021 10(11) - Improved Alzheimer's Disease Detection by MRI Using Multimodal Machine Learning Algorithms.
Battineni Gopi et al. Diagnostics (Basel, Switzerland) 2021 11(11) - JAMIR-eQTL: Japanese genome-wide identification of microRNA expression quantitative trait loci across dementia types.
Akiyama Shintaro et al. Database : the journal of biological databases and curation 2021 2021(2021) - Digital Endpoints: Definition, Benefits, and Current Barriers in Accelerating Development and Adoption.
Landers Matthew et al. Digital biomarkers 2021 5(3) 216-223 - Predicting future amyloid biomarkers in dementia patients with machine learning to improve clinical trial patient selection.
Reith Fabian H et al. Alzheimer's & dementia (New York, N. Y.) 2021 7(1) e12212 - The missing X factor in Alzheimer disease
MT Ferretti et al, Nat Rev Neurology, October 2021 - Investigating Predictors of Preserved Cognitive Function in Older Women Using Machine Learning: Women's Health Initiative Memory Study.
Casanova Ramon et al. Journal of Alzheimer's disease : JAD 2021 - Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
Largent Emily A et al. Journal of Alzheimer's disease : JAD 2021 - Prominent Striatum Amyloid Retention in Early-Onset Familial Alzheimer's Disease With PSEN1 Mutations: A Pilot PET/MR Study.
Qin Qi et al. Frontiers in aging neuroscience 2021 13732159 - Contribution of rare variant associations to neurodegenerative disease presentation.
Dilliott Allison A et al. NPJ genomic medicine 2021 6(1) 80 - A UK-Wide Study Employing Natural Language Processing to Determine What Matters to People about Brain Health to Improve Drug Development: The Electronic Person-Specific Outcome Measure (ePSOM) Programme.
Saunders S et al. The journal of prevention of Alzheimer's disease 2021 8(4) 448-456 - Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review.
Grueso Sergio et al. Alzheimer's research & therapy 2021 13(1) 162 - Prediction of post-stroke cognitive impairment using brain FDG PET: deep learning-based approach.
Lee Reeree et al. European journal of nuclear medicine and molecular imaging 2021 - Genetically determined low income modifies Alzheimer's disease risk.
Wang Rong-Ze et al. Annals of translational medicine 2021 9(15) 1222 - Current uses, emerging applications, and clinical integration of artificial intelligence in neuroradiology.
Fiani Brian et al. Reviews in the neurosciences 2021 - A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
Wightman Douglas P et al. Nature genetics 2021 53(9) 1276-1282 - Scoping review: the empowerment of Alzheimer’s Disease caregivers with mHealth applications
E Kim et al, NPJ Digital Medicine, September 7, 2021 - Unsupervised Machine Learning to Identify Separable Clinical Alzheimer's Disease Sub-Populations.
Prakash Jayant et al. Brain sciences 2021 11(8) - Probability of Alzheimer's disease based on common and rare genetic variants.
Escott-Price Valentina et al. Alzheimer's research & therapy 2021 13(1) 140 - Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer Disease.
Davis Emily J et al. JAMA neurology 2021
More
About ND PHGKB
Neurological Disorders (ND) PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to neurological disorders....more
Content Summary
Common ND Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 18, 2024
- Content source: